What features do Claroty xDome Network Protection vs Rhebo OT Security offer?

**Claroty xDome Network Protection** differentiates with Passive network monitoring for CPS environments, AI-driven CPS library for asset visibility and vulnerability attribution, Safe queries for active asset discovery. **Rhebo OT Security** differentiates with OT network security monitoring and anomaly detection, Risk and vulnerability assessment for OT environments, Asset discovery and documentation of OT devices.

Is Claroty xDome Network Protection a good alternative to Rhebo OT Security?

Claroty xDome Network Protection and Rhebo OT Security serve similar Industrial Control System Security use cases: both are Industrial Control System Security tools, both cover Critical Infrastructure. Review the feature comparison above to determine which fits your requirements.

Claroty xDome Network Protection vs Rhebo OT Security (2026) | Compare Industrial Control System Security Tools

Q: What is the difference between Claroty xDome Network Protection vs Rhebo OT Security?

**Claroty xDome Network Protection**: Network protection for cyber-physical systems in industrial environments. built by Claroty. headquartered in United States. Core capabilities include Passive network monitoring for CPS environments, AI-driven CPS library for asset visibility and vulnerability attribution, Safe queries for active asset discovery.. **Rhebo OT Security**: OT/IIoT network security monitoring, anomaly detection, and asset discovery. built by Rhebo. headquartered in Germany. Core capabilities include OT network security monitoring and anomaly detection, Risk and vulnerability assessment for OT environments, Asset discovery and documentation of OT devices.. Both serve the Industrial Control System Security market but differ in approach, feature depth, and target audience.

Q: Who makes Claroty xDome Network Protection vs Rhebo OT Security?

**Claroty xDome Network Protection** is developed by Claroty. **Rhebo OT Security** is developed by Rhebo. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.